Literature DB >> 10631342

Mutatect: a mouse tumour model for detecting radiation-induced mutations in vivo.

H C Birnboim1, D Wilkinson, J K Sandhu, J R McLean, W Ross.   

Abstract

A new mouse model (Mutatect) that permits detection of mutations at the hprt (hypoxanthine phosphoribosyltransferase) locus is described. It is highly sensitive to detection of mutants induced by clastogenic agents such as ionizing radiation. MN-11 cells are grown as a subcutaneous tumour in C57BL/6 mice for a period of 2 weeks, during which time they can be exposed to mutagenic treatments. Cells taken from the animal are cultured ex vivo and 6-thioguanine (6-TG)-resistant mutant clones can be readily identified and scored. This model system may have special utility for detecting multi-locus deletion events (chromosomal mutations) induced by high LET forms of radiation that might be encountered in space.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10631342     DOI: 10.1016/s0027-5107(99)00139-6

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  4 in total

1.  Expression of interleukin-8 promotes neutrophil infiltration and genetic instability in mutatect tumors.

Authors:  A S Haqqani; J K Sandhu; H C Birnboim
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

2.  Neutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model.

Authors:  J K Sandhu; H F Privora; G Wenckebach; H C Birnboim
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

3.  Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span.

Authors:  Antonello Lorenzini; Adam B Salmon; Chad Lerner; Claudio Torres; Yuji Ikeno; Susan Motch; Roger McCarter; Christian Sell
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-07-20       Impact factor: 6.053

4.  Pardaxin, a fish antimicrobial peptide, exhibits antitumor activity toward murine fibrosarcoma in vitro and in vivo.

Authors:  Shu-Ping Wu; Tsui-Chin Huang; Ching-Chun Lin; Cho-Fat Hui; Cheng-Hui Lin; Jyh-Yih Chen
Journal:  Mar Drugs       Date:  2012-08-22       Impact factor: 6.085

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.